Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation. (Q38779808)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26990590%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

title

Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26990590%20AND%20SRC:MED&resulttype=core&format=json

recurrent hepatocellular carcinoma

11 March 2020

main subject

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26990590%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

author name string

Mitsuo Shimada

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26990590%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Shinichiro Yamada

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26990590%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

publication date

2 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26990590%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26990590%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26990590%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26990590%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

page(s)

23-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26990590%20AND%20SRC:MED&resulttype=core&format=json

The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future).

11 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma: a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Surgical and Locoregional Therapy of HCC: TACE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Microwave ablation of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Scattered and rapid intrahepatic recurrences after radio frequency ablation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

A case of rapid intrahepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Correction: Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating β-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

CD24 is an effector of HIF-1-driven primary tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

HIF-1α and HIF-2α: siblings in promoting angiogenesis of residual hepatocellular carcinoma after high-intensity focused ultrasound ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Phenotypic characterization of human colorectal cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133(high) cancer stem cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

TGF-beta and epithelial-to-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

The snail superfamily of zinc-finger transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Effect of Twist and Bmi1 on intraductal papillary mucinous neoplasm of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

High CD44s expression is associated with the EMT expression profile and intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Correlation between vascular endothelial growth factor levels and prognosis of hepatocellular carcinoma patients receiving radiofrequency ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

Epithelial-mesenchymal transition-related genes are linked to aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12705

21 January 2018

Identifiers

DOI

10.1111/HEPR.12705

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26990590%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference